R Rocha

ORCID: 0000-0002-8527-8751
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Coronary Interventions and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Arrhythmias and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Cardiac Structural Anomalies and Repair
  • Cardiac pacing and defibrillation studies
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Advanced MRI Techniques and Applications
  • Cardiac Valve Diseases and Treatments
  • Voice and Speech Disorders
  • Erythropoietin and Anemia Treatment
  • Cardiac electrophysiology and arrhythmias
  • Potassium and Related Disorders
  • Pericarditis and Cardiac Tamponade
  • Tracheal and airway disorders
  • Psychology and Mental Health
  • Coronary Artery Anomalies
  • Sarcoidosis and Beryllium Toxicity Research
  • Cardiac Health and Mental Health

Direcção Regional de Cultura do Alentejo
2023-2024

Hospital do Espírito Santo
2019-2024

Novartis (United States)
2019

Previous work has suggested that diaphragm EMGs recorded from the lower thoracic wall yield spuriously low centroid frequencies (Fc). For this reason we compared two anterolateral locations with simultaneously a bipolar esophageal electrode in 11 stable quadriplegic patients. Their maximal inspiratory pressures (Pdimax) ranged 31 to 85, averaging 55 cm H2O. Quadriplegic patients were selected exclude EMG contamination of surface recordings by intercostal muscle activity. Recordings made...

10.1164/ajrccm/147.3.764 article EN American Review of Respiratory Disease 1993-03-01

Ischemic heart disease is the single most common cause of death in Europe. Mortality patients presenting with ST-elevation myocardial infarction (STEMI) associated many factors, one which time delay to treatment. The purpose this work analyze coronary pathway our region terms timing, taking into consideration place first medical contact (FMC).

10.1016/j.repc.2024.02.007 article EN cc-by-nc-nd Revista Portuguesa de Cardiologia 2024-04-24

Abstract Funding Acknowledgements Type of funding sources: None. Background Cardiac arrest is a feared complication cardiovascular disease, even in inpatient context, and requires swift precise management to avoid increasing morbimortality. Identifying which patients are at greater risk could potentially improve outcomes. Purpose We aim identify if ST-segment elevation related with higher incidence intra-hospital cardiac arrest. Methods analysed population 940 (C) admitted ACS divided them...

10.1093/eurjpc/zwad125.057 article EN European Journal of Preventive Cardiology 2023-05-24

We describe a case of aortic rupture following transcatheter valve implantation that was managed percutaneously.

10.5837/bjc.2024.008 article EN British Journal of Cardiology 2024-01-01

Abstract Background The efficacy, safety, and tolerability of an angiotensin receptor-neprilysin inhibitor (ARNi) in patients presenting with de novo heart failure (HF) has not been previously well-defined. Methods PIONEER-HF trial was a prospective, multicenter, double-blind, active-controlled, randomized clinical which enrolled 887 (pts) at 129 sites the United States. Pts or without history prior HF ejection fraction (EF) <40% NT-proBNP >1600 pg/mL BNP >400 were eligible for...

10.1093/eurheartj/ehz748.0004 article EN European Heart Journal 2019-10-01

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Cardiogenic Shock(CS)complicates 10%of Acute Myocardial Infarction(AMI), being the main cause for intra-hospital death in these patients.Although early revascularization has contributed to increase survival,mortality still presents high, 40-50%.CS usually with inadequate cardiac output and persistent hypotension.However,after large AMI,peripheral hypoperfusion can occur sustained or borderline systolic blood...

10.1093/ehjacc/zuab020.039 article EN European Heart Journal Acute Cardiovascular Care 2021-04-01

We present a technique for aortic composite graft implantation after left ventricular outflow tract destruction due to its proximal dehiscence.A 53-year-old gentleman with rheumatoid arthritis and history of Bentall procedure, presented heart failure symptoms the past month. Transthoracic echocardiogram identified prosthetic valve dysfunction, transesophageal detected that mechanism was by dehiscence. After excluding infectious etiology, it hypothesized cause absence endothelialization,...

10.1186/s43044-022-00307-4 article EN cc-by The Egyptian Heart Journal 2022-11-08

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Acute Pulmonary embolism(PE)is a common and potentially fatal medical condition.In contemporary adult population,PE is associated with increased long-term mortality. Purpose Identify predictors all-cause mortality in patients(pts)admitted due to pulmonary embolism. Methods Retrospective single-center study hospitalized pts acute PE between 2015 2018.We evaluated comorbidities, admission(AD)presentation such as...

10.1093/ehjacc/zuab020.197 article EN European Heart Journal Acute Cardiovascular Care 2021-04-01

Abstract Funding Acknowledgements Type of funding sources: None. Introduction The presence Atrial Fibrillation (AF) in Acute Myocardial Infarction (AMI) is an important challenge antiplatelet and anticoagulant therapy may have impact on the prognosis these patients. Purpose To determine incidence AF during hospitalization for ST-elevated AMI (STEMI), identify possible predictors its onset assess mortality. Methods We studied 3254 patients with diagnosis STEMI included a multicenter national...

10.1093/ehjacc/zuad036.062 article EN European Heart Journal Acute Cardiovascular Care 2023-05-01

Abstract Funding Acknowledgements Type of funding sources: None. Background It is established that the presence anaemia associated with a higher number complications in patients myocardial infarction (MI). However, even without history anaemia, haemoglobin (Hb) drop often observed. The impact this decrease incidence heart failure (HF), cardiogenic shock (CS) and reinfarction still unclear. Purpose This retrospective observational study aims to document if Hb greater than 2g/dL MI previous...

10.1093/ehjacc/zuad036.132 article EN European Heart Journal Acute Cardiovascular Care 2023-05-01

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Patients with acute coronary syndrome (ACS) may develop ventricular dysfunction and need to use drugs a positive inotropic effect during the phase. Despite hemodynamic benefit these drugs, have several side effects. Among these, arrhythmias atrial fibrillation. Levosimendan is drug that increases sensitivity myocardium calcium, producing effect. Purpose This study aims assess frequency occurrence dysrhythmic...

10.1093/ehjacc/zuad036.032 article EN European Heart Journal Acute Cardiovascular Care 2023-05-01

Abstract Funding Acknowledgements Type of funding sources: None. Background Despite advancements in stent technology, such as the appearance drug-eluting stents, restenosis remains a common post-procedure complication and is associated with higher morbimortality. These patients frequently need repeat revascularisation pose therapeutic challenge. Purpose This study aims to characterize if it possible identify clinical predictors restenosis. Methods We retrospectively observed population 9815...

10.1093/ehjacc/zuad036.167 article EN European Heart Journal Acute Cardiovascular Care 2023-05-01

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Peripheral artery disease (PAD) is an important co-morbidity in non-ST-segment elevation acute coronary syndromes (NSTEMI), and its presence may affect the therapeutic approach prognosis these patients. Purpose To assess impact PAD on approach, clinical outcome, in-hospital 1-year mortality patients with NSTEMI. Methods We studied 7248 NSTEMI included a national multicenter registry. considered 2 groups: without...

10.1093/ehjacc/zuad036.063 article EN European Heart Journal Acute Cardiovascular Care 2023-05-01

Abstract Funding Acknowledgements Type of funding sources: None. Background Acute coronary syndrome (ACS) remains a frequent cause hospital admission, with its prognosis depending on many factors, one being the location culprit lesion. It is established that anterior myocardial infarction, caused mostly by left descending artery occlusion associated worse and higher morbimortality. Therefore, identifying patients at risk significant LAD lesions could potentially impact outcomes. Purpose We...

10.1093/eurjpc/zwad125.055 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Patients with Heart Failure (HF) usually have multiple co-morbidities, so their approach in the context Acute Coronary Syndrome (ACS) could be an important challenge. Purpose To characterize patients ACS and previous HF evaluate its impact on therapeutic approach, complications in-hospital mortality. Methods We studied 745 admitted to a Cardiac Intensive Care Unit diagnosis ACS. considered 2 groups: without history...

10.1093/eurjpc/zwad125.146 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Introduction NT-proBNP is a cardiac biomarker with diagnostic and prognostic value. Assessment enables to determine, or exclude, cause dyspnea, variations in its levels are significantly related prognosis, as higher values heart failure have worse prognosis than those reduction Acute might be associated acute coronary syndromes (ACS) may require inotropic therapy improve hemodynamic status optimize output. Inotropes help...

10.1093/eurjpc/zwad125.213 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Background Despite advancements in stent technology, such as the appearance drug-eluting stents, restenosis remains a common post-procedure complication and is associated with higher morbimortality. These patients frequently need repeat revascularisation pose therapeutic challenge. Purpose This study aims to characterise if it possible identify clinical predictors restenosis. Methods We retrospectively observed population 9815...

10.1093/eurjpc/zwad125.058 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Antithrombotic therapy is the cornerstone treatment for acute coronary syndromes. Often, parenteral anticoagulation (AC) added to dual antiplatelet treatment, till primary percutaneous intervention (PCI). This strategy recommended by latest guidelines, due large experience, however, there has been no placebo-controlled trial evaluating efficacy or safety AC in PCI. Purpose study aims evaluate and with AC, either...

10.1093/eurjpc/zwad125.216 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Background Statin therapy is nowadays a cornerstone in primary and secondary prevention cardiovascular events. Purpose This retrospective observational study intends to characterise the influence previous with statins on clinical electrocardiographic presentation acute coronary syndrome (ACS) in-hospital morbidity mortality. Methods We evaluated population 746 patients admitted Cardiac Care Intensive Unit diagnosed ACS (D)....

10.1093/eurjpc/zwad125.082 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Background Chronic obstructive pulmonary disease (CPOD) is a common comorbidity in patients admitted with myocardial infarction (MI) and needs to be considered since it can condition therapeutic approach potentially negatively impact their prognosis. Purpose We aim evaluate the CPOD approach, clinical course in-hospital mortality MI. Methods retrospectively analysed population 2797 MI (C). divided them into two distinct groups:...

10.1093/eurjpc/zwad125.083 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Patients with a history Acute Myocardial Infarction (AMI) continue to be underrepresented in large studies on Coronary Syndromes (ACS). Purpose To characterize patients ACS and previous AMI evaluate their impact the therapeutic approach, complications in-hospital mortality. Methods We studied 722 admitted Cardiac Intensive Care Unit diagnosis ACS. considered 2 groups: without AMI. Age, gender, personal history,...

10.1093/eurjpc/zwad125.152 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Funding Acknowledgements Type of funding sources: None. Background In patients with acute coronary syndromes (ACS), the occurrence intra-hospital cardiac arrest is a medical emergency challenging approach, especially when it unpredictable, and remains associated higher morbimortality. The correct identification at greater risk closer monitoring could potentially improve outcomes. Purpose This study aims to characterise if establishment left ventricular (LV) dysfunction after ACS...

10.1093/eurjpc/zwad125.056 article EN European Journal of Preventive Cardiology 2023-05-24
Coming Soon ...